These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 2830885
1. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Binderup L, Bramm E. Biochem Pharmacol; 1988 Mar 01; 37(5):889-95. PubMed ID: 2830885 [Abstract] [Full Text] [Related]
2. Calcipotriol (MC 903): pharmacokinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3. Kissmeyer AM, Binderup L. Biochem Pharmacol; 1991 Jun 01; 41(11):1601-6. PubMed ID: 2043150 [Abstract] [Full Text] [Related]
3. Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: effects on cell growth regulation in vitro and calcium metabolism in vivo. Binderup L. Pharmacol Toxicol; 1993 Jun 01; 72(4-5):240-4. PubMed ID: 8396769 [Abstract] [Full Text] [Related]
4. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Colston KW, Chander SK, Mackay AG, Coombes RC. Biochem Pharmacol; 1992 Aug 18; 44(4):693-702. PubMed ID: 1324683 [Abstract] [Full Text] [Related]
5. Structure function analysis of vitamin D analogs with C-ring modifications. Bouillon R, Allewaert K, van Leeuwen JP, Tan BK, Xiang DZ, De Clercq P, Vandewalle M, Pols HA, Bos MP, Van Baelen H. J Biol Chem; 1992 Feb 15; 267(5):3044-51. PubMed ID: 1310680 [Abstract] [Full Text] [Related]
6. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Norman AW, Sergeev IN, Bishop JE, Okamura WH. Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333 [Abstract] [Full Text] [Related]
7. The effects of MC903 on 1,25-(OH)2D3 receptor binding, 24-hydroxylase activity and in vitro bone resorption. Pols HA, Birkenhäger JC, Schilte JP, Bos MP, van Leeuwen JP. Bone Miner; 1991 Aug 01; 14(2):103-11. PubMed ID: 1655130 [Abstract] [Full Text] [Related]
8. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia. Jung SJ, Lee YY, Pakkala S, de Vos S, Elstner E, Norman AW, Green J, Uskokovic M, Koeffler HP. Leuk Res; 1994 Jun 01; 18(6):453-63. PubMed ID: 8207963 [Abstract] [Full Text] [Related]
9. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Zhou JY, Norman AW, Akashi M, Chen DL, Uskokovic MR, Aurrecoechea JM, Dauben WG, Okamura WH, Koeffler HP. Blood; 1991 Jul 01; 78(1):75-82. PubMed ID: 1648977 [Abstract] [Full Text] [Related]
10. Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells. Valaja T, Mahonen A, Pirskanen A, Mäenpää PH. Biochem Pharmacol; 1990 Oct 15; 40(8):1827-32. PubMed ID: 2173591 [Abstract] [Full Text] [Related]
11. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells. Siu-Caldera ML, Clark JW, Santos-Moore A, Peleg S, Liu YY, Uskoković MR, Sharma S, Reddy GS. J Steroid Biochem Mol Biol; 1996 Dec 15; 59(5-6):405-12. PubMed ID: 9010346 [Abstract] [Full Text] [Related]
12. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP. Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153 [Abstract] [Full Text] [Related]
13. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. Mathiasen IS, Colston KW, Binderup L. J Steroid Biochem Mol Biol; 1993 Sep 01; 46(3):365-71. PubMed ID: 9831485 [Abstract] [Full Text] [Related]
14. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. Bouillon R, Allewaert K, Xiang DZ, Tan BK, van Baelen H. J Bone Miner Res; 1991 Oct 01; 6(10):1051-7. PubMed ID: 1796753 [Abstract] [Full Text] [Related]
15. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization. Zhou JY, Norman AW, Lübbert M, Collins ED, Uskokovic MR, Koeffler HP. Blood; 1989 Jul 01; 74(1):82-93. PubMed ID: 2665845 [Abstract] [Full Text] [Related]
16. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines. Gniadecki R. Br J Pharmacol; 1997 Mar 01; 120(6):1119-27. PubMed ID: 9134225 [Abstract] [Full Text] [Related]
17. Calcipotriol: a new drug for topical psoriasis treatment. Kragballe K. Pharmacol Toxicol; 1995 Oct 01; 77(4):241-6. PubMed ID: 8577633 [Abstract] [Full Text] [Related]
18. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner. Svendsen ML, Daneels G, Geysen J, Binderup L, Kragballe K. Pharmacol Toxicol; 1997 Jan 01; 80(1):49-56. PubMed ID: 9148283 [Abstract] [Full Text] [Related]
19. Synthesis and biological activity of (22E,25R)- and (22,25S)-22-dehydro- 1 alpha,25-dihydroxy-26-methylvitamin D3. Hara N, Eguchi T, Ikekawa N, Ishizuka S, Sato J. J Steroid Biochem; 1990 May 01; 35(6):655-64. PubMed ID: 2163469 [Abstract] [Full Text] [Related]
20. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3. Bouillon R, Sarandeses LA, Allewaert K, Zhao J, Mascareñas JL, Mouriño A, Vrielynck S, de Clercq P, Vandewalle M. J Bone Miner Res; 1993 Aug 01; 8(8):1009-15. PubMed ID: 8213251 [Abstract] [Full Text] [Related] Page: [Next] [New Search]